Pharmacokinetics of TKM-130803 in Ebola virus disease in Sierra Leonean subjects

Podobne zapisy

• Pharmacokinetics of TKM-130803 in Ebola virus disease in Sierra Leonean patients
  od: Scott, JT, i wsp.
  Wydane: (2019)
• Pharmacokinetics of TKM-130803 in Sierra Leonean patients with Ebola virus disease: Plasma concentrations exceed target levels, with drug accumulation in the most severe patients
  od: Scott, JT, i wsp.
  Wydane: (2020)
• Pharmacokinetics of TKM-130803 in Sierra Leonean patients with Ebola virus disease:  plasma concentrations exceed target levels, with drug accumulation in the most severe patients
  od: Janet T. Scott, i wsp.
  Wydane: (2020-02-01)
• Experimental treatment of Ebola virus disease with TKM-130803: A single-arm phase 2 clinical trial.
  od: Dunning, J, i wsp.
  Wydane: (2016)
• Experimental treatment of Ebola virus disease with TKM-130803: a single-arm phase 2 clinical trial
  od: Dunning, J, i wsp.
  Wydane: (2016)